Method for simultaneously detecting an antigen of, and an antibody against, an infectious microorganism

1. A method for detecting, in vitro, an infection with human immunodeficiency virus (HIV) in a biological sample, comprising simultaneous detection of at least one gag antigen of said HIV and of an antibody directed against said at least one gag antigen of said HIV present in the biological sample, wherein said HIV is at least one HIV-1, and wherein said at least one gag antigen is at least one HIV-1 p25 protein, which method comprises

a) bringing the biological sample into contact with a capture antibody directed against said gag antigen of said HIV, and a capture gag antigen derived from said HIV;

b) incubating the mixture under conditions allowing formation of antigen-antibody complexes;

c) revealing the antigen-antibody complexes formed which uses a labeled detection antibody capable of binding to the gag antigen of said HIV which has been captured and/or also a labeled detection HIV gag antigen capable of binding to the gag antigen antibody which has been captured;

wherein the capture gag antigen and/or the labeled detection gag antigen comprises an antigenic gag fragment of said HIV in which at least one epitope has been destroyed;

wherein the capture and/or detection antibody recognizes said at least one epitope, which is intact, of the gag antigen which has been captured; and

d) the presence of capture antibody/antigen complexes and of antibody/capture antigen complexes indicates an infection with HIV;

wherein the capture gag antigen consists of sequence

(SEQ ID NO: 22)

FRGYVGRFYKTLRAEQAGQGVKNFMTETLLVQNANPDCKTILKALGPAA

TLEEMMTAC

 and/or the labeled detection gag antigen consists of labeled sequence

(SEQ ID NO: 22)

FRGYVGRFYKTLRAEQAGQGVKNFMTETLLVQNANPDCKTILKALGPAA

TLEEMMTAC.

2. The method as claimed in claim 1 , in which said capture antibody and said capture gag antigen are immobilized on a solid phase.

3. The method as claimed in claim 1 , in which the detection antibody is added to the mixture after the antigen-antibody complexes have formed.

4. The method as claimed in claim 1 , in which the detection antibody and/or the detection antigen is brought into contact with the biological sample at the same time as the capture antibody and the capture gag antigen.

5. The method of detection as claimed in claim 1 , comprising:

a) bringing the sample into contact with the capture antibody and the capture gag antigen attached to a solid phase;

b) incubating the mixture under conditions allowing the formation of antigen-antibody complexes;

c) separating the solid phase and the liquid phase;

d) bringing the solid phase into contact with a labeled detection antibody capable of binding the gag antigen which has been captured, and one or more labeled detection HIV gag antigens capable of binding the gag antigen antibody which has been captured;

wherein the capture gag antigen consisits of sequence

(SEQ ID NO: 22)

FRGYVGRFYKTLRAEQAGQGVKNFMTETLLVQNANPDCKTILKALGPAA

TLEEMMTAC

 and/or the labeled detection gag antigen consisits of labeled sequence

(SEQ ID NO: 22)

FRGYVGRFYKTLRAEQAGQGVKNFMTETLLVQNANPDCKTILKALGPAA

TLEEMMTAC,

 and wherein the capture and/or detection antibody each recognizes one of said epitopes, which are intact, of the gag antigen which has been captured.

6. The method as claimed in claim 5 , in which the capture antibody and the detection antibody each recognizes an epitope of sequence

QASQEVKNWMTETLL

(SEQ ID NO: 24).

7. The method as claimed in claim 5 , in which the biological sample is brought into contact with said capture antibody and said capture gag antigen attached to a solid phase, in the presence of at least one detergent of the nonionic type.

8. The method as claimed in claim 7 , in which said nonionic detergent is NP40.

9. The method as claimed in claim 1 , in which the HIV-1 p25 protein consists of sequence SEQ ID NO: 23.